Example: Heart Attack

Clinical Trials Sponsored by ICON Clinical Research

Total 48 results

NCT04683250

Recruiting

Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities

Conditions: RET-altered Non Small Cell Lung Cancer; RET-altered Solid Tumors
NCT04209543

Recruiting

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Conditions: Vasomotor Symptoms; Menopausal Symptoms
NCT04090957

Recruiting

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women

Conditions: Vasomotor Symptoms; Menopausal Symptoms
NCT03849469

Recruiting

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Conditions: Melanoma; Cervical Carcinoma; Pancreatic Carcinoma; Triple Negative Breast Cancer; Hepatocellular Carcinoma; Urothelial Carcinoma; Squamous Cell Carcinoma of the Head and Neck; Nasopharyngeal Carcinoma; Renal Cell Carcinoma; Non-small Cell Lung Carcinoma; Small Cell Lung Carcinoma; Gastric or Gastroesophageal Junction Adenocarcinoma; Advanced or Metastatic Solid Tumors; Prostate Carcinoma; MSI-H; Mismatch Repair Deficiency; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Intrahepatic Cholangiocarcinoma
NCT03806179

Recruiting

Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL

Conditions: Non Hodgkin Lymphoma; Follicular Lymphoma; Relapsed Follicular Lymphoma
NCT03744910

Recruiting

Interleukin 6 Blockade Modifying Antibody-Mediated Graft Injury and Estimated Glomerular Filtration Rate (eGFR) Decline

Conditions: Antibody-mediated Rejection
NCT03216486

Withdrawn

An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta

Conditions: Osteogenesis Imperfecta
NCT03185832

Completed

Heart Failure and Sudden Cardiac Death Japan Registry

Conditions: Heart Failure; Arrhythmias, Cardiac; Sudden Cardiac Death
NCT03118570

Active, not recruiting

A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804

Conditions: Osteogenesis Imperfecta, Type I; Osteogenesis Imperfecta Type III; Osteogenesis Imperfecta Type IV
NCT03060746

Completed

Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects

Conditions: Helicobacter Pylori Infection; Gastric Ulcer; Nausea; Abdominal Pain; Weight Loss; Stomach Ulcer; Loss of Appetite; Bloating
NCT03060733

Completed

Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects

Conditions: Helicobacter Pylori Infection; Gastric Ulcer; Nausea; Abdominal Pain; Weight Loss; Stomach Ulcer; Loss of Appetite; Bloating
NCT02924402

Recruiting

Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies

Conditions: B-cell Non-Hodgkins Lymphoma; Chronic Lymphocytic Leukemia
NCT02763319

Recruiting

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Conditions: Diffuse Large B-cell Lymphoma
NCT02730312

Recruiting

PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies

Conditions: Acute Myelogenous Leukemia; B-cell Acute Lymphoblastic Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm; Chronic Myeloid Leukemia, Blast Crisis
NCT02727699

Completed

A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)

Conditions: Dementia, Alzheimer Type
NCT02351635

Completed

BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS

Conditions: Inflammatory Bowel Disease; Irritable Bowel Syndrome
NCT02074579

Completed

A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome

Conditions: Irritable Bowel Syndrome in Females
NCT02065336

Terminated

A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Conditions: Hepatitis B, Chronic
NCT02047344

Completed

Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC

Conditions: Non-small Cell Lung Cancer Stage IV
NCT01809912

Terminated

Safety Study of MG1102 in Patients With Solid Tumors

Conditions: Solid Tumors
NCT01796171

Recruiting

A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma

Conditions: Non-Hodgkin Lymphoma; Follicular Lymphoma
NCT01572909

Completed

Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

Conditions: Reperfusion Injury; STEMI
NCT01545076

Completed

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)

Conditions: Chronic Inflammatory Demyelinating Polyneuropathy; Polyradiculoneuropathy
NCT01453608

Completed

A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency

Conditions: Iron Deficiency; Chronic Heart Failure
NCT01350362

Completed

Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients

Conditions: Alzheimer's Disease